March 16, 2015

Community Pharmacy: The face of neighborhood health care in America

March 10, 2015

There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales. 

February 23, 2015

The Drug Store News Group capped off 2014 with a bang as some of the top minds in pharmacy retailing gathered for the 16th annual Industry Issues Summit on Dec. 3 to take part in a candid discussion of the top issues and trends impacting the industry.

February 12, 2015

In a series of special reports, Drug Store News looks at some of the top trends impacting pharmacy in this pivotal year for the nation’s health system.

 

January 29, 2015

In December, DSN hosted its 14th annual Diabetes Roundtable, this time expanding the discussion to include other chronic conditions and community pharmacy’s role in driving prevention and improved health outcomes for patients.

August 20, 2014

While drug stores across North America have diversified their mix over the past few years, over-the-counter medications remain at the heart of most every pharmacy retailer’s efforts, helping to maintain the drug channel’s inherent value as a front-line healthcare provider and the outlet of choice for consumers suffering from a wide range of minor illnesses.

October 10, 2013

Like politics, retailing is local. That inescapable fact is behind the ongoing build-up of Health Mart’s local marketing and patient care initiatives as McKesson shifts more store support muscle to the more than 3,100 independent pharmacies allied with the Health Mart network through its Local Marketing Support Program.

October 10, 2013

Christian Tadrus, PharmD, who has been a pharmacist at Sam’s Health Mart Pharmacies in Moberly, Mo., since 1997, is a believer in using patient adherence strategies to help boost pharmacy operations. And with the implementation of health reform, adherence will be a key differentiator between pharmacies — a measurable indicator of quality of care.

October 10, 2013

“The best of a chain combined with the best of an independent pharmacy.”

That’s how Health Mart president Steve Courtman describes Health Mart’s “unique value proposition in the marketplace.” That value, he added, is defined every day in thousands of communities across the United States by the pharmacy owner-operators who serve as the most accessible and most-utilized patient care providers in their local healthcare networks.

October 10, 2013

Quantity and quality: Those are the two metrics by which any pharmacy operation is measured — quantity of prescriptions dispensed and quality of services provided. Quantity keeps you in business; quality keeps your patients coming back.

It’s a constant challenge for a small operator to score high on both metrics, but that’s exactly what McKesson’s 2013 Pharmacy of the Year Award recipient Parkland Health Mart Pharmacy, of Desloge, Mo., has done.

October 10, 2013

One of Health Mart’s newest owners is Yang Xiong, who opened Minneapolis’ Northside Community Health Mart Pharmacy in July. A 2011 graduate of the College of Pharmacy at the University of Minnesota, Xiong spent his first years working for two national chains. That experience led him to want to operate his own pharmacy and have a more direct impact on his patients.

October 10, 2013

There are many ways a pharmacy operation can measure success; the most basic is to fill more prescriptions today than yesterday.

October 10, 2013

For Tom Davis, co-owner of Kiowa Health Mart Pharmacy, in Eads, Colo., technology has always been critical to the operation. “We put in our first pharmacy system in 1982. At the time, we may have been one of the first systems in Colorado, to be honest,” Davis told DSN.

October 10, 2013

In 2006, Health Mart was a loosely cohesive buying and marketing group of 268 independently owned and operated drug stores, falling under McKesson Corp.’s store-support umbrella via its purchase of the old FoxMeyer wholesale business in the mid-1990s. Today, just seven years after its reinvention and relaunch by McKesson, Health Mart is the nation’s biggest independent pharmacy franchise and one of the fastest-growing drug store networks of any kind, with more than 3,100 member stores doing business in thousands of communities across the United States.

May 9, 2013

Success in the mass market can be an uphill battle for some niche brands as retailers trim selection, bolster private-label offerings and pass on smaller brands they perceive as higher risk. However, retailers also are increasingly looking to distinguish themselves from the competition, whether it is through exclusive offerings, customization or in-store services.

February 28, 2013

The battle over "pay for delay" continues to heat up, and its resolution likely won't come until the nation's highest court decides on the legality of the practice.

February 28, 2013

Canadian generic drug makers expressed dismay over a new plan to reduce reimbursements for a half-dozen generic medications in most of the country's provinces. According to published reports, a group of premiers had reached a coordinated deal to reduce the prices their governments paid for six generic drugs, hoping to save the provinces nearly $100 million.

February 28, 2013

Alabama's Supreme Court ruled in January that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

February 28, 2013

The Food and Drug Administration has set user fee rates for generic drug companies, the agency said Jan. 27.

February 28, 2013

It's been long accepted that politics makes strange bedfellows. That's certainly the case with the reauthorization in 2012 of the Prescription Drug User Fee Act.

February 28, 2013

Has the explosion in generic utilization curbed pioneer-drug research and development? That's one concern floated by some pharmaceutical industry watchers, who claim that the stunning market share gains made by generic drug makers could reduce incentives for branded drug companies to spend to develop new molecular entities, conduct lengthy clinical trials, gain FDA approval and bring those new drugs to market.

February 28, 2013

The world market for generic drugs will jump more than 15% this year and reach a global total of $127.8 billion, predicted a report from British market research firm Visiongain.

February 28, 2013

Biosimilar medicines have been approved and routinely prescribed in Europe for nearly seven years, and creation of a clear pathway for Food and Drug Administration review and approval of generic versions of bioengineered drugs was enshrined into law in the United States with the passage of the Patient Protection and Affordable Care Act nearly three years ago.

February 28, 2013

Pharmacy benefit managers are becoming increasingly adept at leveraging the power of generics to save client healthcare dollars and improve their own standing, reports indicated.